REPL Stock Summary and Trading Ideas (Replimune Group | NASDAQ:REPL)

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Replimune Group trades on the NASDAQ stock market under the symbol REPL.

As of December 18, 2025, REPL stock price climbed to $9.69 with 1,051,448 million shares trading.

REPL has a beta of 0.51, meaning it tends to be less sensitive to market movements. REPL has a correlation of 0.00 to the broad based SPY ETF.

REPL has a market cap of $760.12 million. This is considered a Small Cap stock.

Last quarter Replimune Group reported $0 in Revenue and -$.90 earnings per share. This fell short of revenue expectation by $-500,000 and missed earnings estimates by -$.08.

In the last 3 years, REPL traded as high as $29.52 and as low as $2.68.

The top ETF exchange traded funds that REPL belongs to (by Net Assets): IWM, VTI, XBI, VXF, IWN.

REPL has underperformed the market in the last year with a price return of -17.3% while the SPY ETF gained +13.1%. However, in the short term, REPL had mixed performance relative to the market. It has outperformed in the last 3 months, returning +69.7% vs +2.9% return in SPY. But in the last 2 weeks, REPL shares have been beat by the market, returning -6.1% compared to an SPY return of -1.1%.

REPL support price is $9.27 and resistance is $10.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that REPL shares will trade within this expected range on the day.